Gene · 2243
NIH grants1,534
NIH grants whose papers are about the gene, through NIH's grant-paper links.
41 to 60 of 1,534
Download this page as JSON| Grant | Title | FGA papers | Newest fiscal year |
|---|---|---|---|
| P30ES017885 | Michigan Center on Lifestage Environmental Exposures and Disease (M-LEEaD) | 2 | 2025 |
| P50AA024337 | The Role of Nutrition in the Development/Progression of Alcohol-Induced Organ Injury | 2 | 2025 |
| R01DK130294 | Novel Biomarkers for Post-Liver Transplant NASH Fibrosis | 2 | 2025 |
| R01DK133454 | Vinyl chloride modifies the risk for nonalcoholic fatty liver disease | 2 | 2025 |
| R01HL086694 | From GWAS loci to blood pressure genes, variants & mechanisms - Renewal | 2 | 2025 |
| R01HL141291 | Using genomics and functional biology to understand fibrinogen and factor XIII and their effects on thrombotic diseases | 2 | 2025 |
| R01HL161004 | The paradoxical response to iron in pulmonary hypertension of sickle cell disease | 2 | 2025 |
| R01NS017950 | Precursors of Stroke Incidence and Prognosis | 2 | 2025 |
| R50CA211499 | A proteomics research specialist in developing targeted mass spectrometry methods for quantifying proteins important in cancer | 2 | 2025 |
| U54GM115428 | Mississippi Center for Clinical and Translational Research | 2 | 2025 |
| UL1TR001863 | Yale Clinical and Translational Science Award | 2 | 2025 |
| ZIAHL001048 | Nmr Studies Of The Regulation Of Cell Signaling | 2 | 2025 |
| F30CA265288 | Defining and targeting the lung cancer progenitor cell niche using a high-resolution, multi-omics approach | 1 | 2025 |
| I01BX002301 | Combining Immune Therapy with Targeted Therapies to Improve Melanoma Survival | 1 | 2025 |
| I01BX002551 | Mechanisms of microvascular thrombosis in inflammation | 1 | 2025 |
| I01BX005093 | Pathogenic role of a protein complex of liver origin as regulator of a proinflammatory program that drives hepatic and intestinal injury in alcoholic liver disease | 1 | 2025 |
| K12CA086913 | Paul Calabresi Award in Clinical Oncology Research | 1 | 2025 |
| K12CA090433 | PEDIATRIC ONCOLOGY CLINICAL RESEARCH TRAINING PROGRAM | 1 | 2025 |
| K12CA138464 | UC Davis Paul Calabresi K12 Clinical Oncology Research Career Development Program | 1 | 2025 |
| K12CA184746 | MSK Paul Calabresi Career Development Award for Clinical Oncology | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2243/grants?page=3